DFX Intelligence
Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Firms / L••••• C•••••• P•••••••
L••••• C•••••• P•••••••
L••••• C•••••• P••••••• devotes world-class resources to exceptional, developing middle-market healthcare and life science companies. Diligent focus, collaborative partnerships and the Value Creation Program differentiate our firm. At L•••••, companies not only grow; they prosper.
Classification
- Class
- Buyout firmconfirmed, confidence 85%
- Basis
- R6: 25 of 25 distinct vehicles are sworn Private Equity Funds; 23 reported gross assets on a filing in 2022 or later
- Size band
- Upper middle marketdefined by: proxy: $7.95bn Private Equity Fund GAV on the Form ADV filed 2024-08-15
Classification history (1)
- Sep 13, 2026Buyout firm (confirmed, 85%, cls-pe-1)R6: 25 of 25 distinct vehicles are sworn Private Equity Funds; 23 reported gross assets on a filing in 2022 or later
Regulatory footprint (Form ADV)
- Adviser type
- registered investment adviser
- Form ADV filings
- Feb 14, 2012 to Aug 15, 2024
- RAUM
- $7.9Bregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 19
- PE fund GAV, latest filing
- $7.9Breported gross assets (Form ADV), not fund size
- All private fund GAV
- $7.9Bevery private fund type, latest filing
- 2024 PE fund GAV
- $7.9Bsum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 100%
- Fund type mix
- filed 2024-08-15, latest gav Private Equity Fund $7.9B, latest counts Private Equity Fund 19, lifetime distinct Private Equity Fund 25
- Employees
- 40
- Headquarters
- Chicago, IL
- Office address
- 110 NORTH WACKER DRIVE, 55TH FLOOR, Chicago, IL, 60606
- Business phone
- 312-506-5600
Stated criteria beside observed behaviour
54 observed deals
Stated by the firm
- Sectors
- healthcare, energy, life sciences
- Geography
- not stated or not yet read
- Revenue
- not stated or not yet read
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- not stated or not yet read
- Thesis
- When we take on a new hire, a new operating partner, engage in a strategic relationship, or invest in a company, we commit to investing the time, energy, focus and resources necessary to shepherd each commitment through to an exceptional standard.
Observed from deals on record
- roles
- unknown 55
- period
- to 2026-08-24, from 2026-08-24, undated holdings 54, dated observations 2
- window
- last 2026-08-24, first 2026-08-24
- control
- unknown 55
- companies
- 54
- geography
- investments
- 55
- seller kinds
- transactions
- 1
- cadence by year
- 2026 other deals 1
- platform add on
- add ons 0, platforms 0, add ons per platform unknown
- sector known for
- 11
- disclosed value usd
- n 0
- sector distribution
- count 5, share 0.093, value healthcare services, examples ArtesRx, VetEvolve, Drayer Physical Therapy Institute, Avalign Technologies, count 3, share 0.056, value life sciences, examples ILC Dover, RQM+, Regenity Biosciences, count 1, share 0.019, value education, examples Spear Education, count 1, share 0.019, value industrial manufacturing, examples Ranir, LLC, count 1, share 0.019, value energy, examples Solara Medical Supplies
- holding period years
- n 0
- repeat counterparties
- subsector distribution
- count 2, share 0.037, value medical devices, examples RQM+, Regenity Biosciences, count 1, share 0.019, value education, examples Spear Education, count 1, share 0.019, value other ambulatory, examples ArtesRx, count 1, share 0.019, value veterinary, examples VetEvolve, count 1, share 0.019, value physical occupational therapy, examples Drayer Physical Therapy Institute, count 1, share 0.019, value life sciences, examples ILC Dover, count 1, share 0.019, value miscellaneous manufacturing, examples Ranir, LLC, count 1, share 0.019, value energy, examples Solara Medical Supplies
54 companies on the graph (1 transactions); most in healthcare services (5); observed 2026 to 2026
Funds
25 on record
| Fund | Vehicle | Vintage | Reported gross assets (Form ADV), not fund size | GAV by year | Form D sold | Lifecycle |
|---|---|---|---|---|---|---|
| L••••• O••••••••• F••• L• ADV: Private Equity Fund | buyout or unlabelled | 2023 first reported on Form ADV | $581M as of Aug 15, 2024 | no Form D | Unknown | |
| L••••• S••••••••• C•••••• F••• I• L• ADV: Private Equity Fund | buyout or unlabelled | 2023 first reported on Form ADV | $232M as of Aug 15, 2024 | no Form D | Early deployment | |
| L••••• C•••••• P••••••• V•• A•• L• ADV: Private Equity Fund | Buyout fund | 2023 first reported on Form ADV | $218M as of Aug 15, 2024 | no Form D | Early deployment | |
| L••••• C•••••• P••••••• V• A•• L• ADV: Private Equity Fund | Buyout fund | 2023 first reported on Form ADV | $139M as of Aug 15, 2024 | no Form D | Early deployment | |
| L••••• S••••••••• C•••••• F••• I••• L• ADV: Private Equity Fund | Feeder or parallel | 2023 first reported on Form ADV | $28.1M as of Aug 15, 2024 | no Form D | Early deployment | |
| L••••• C•••••• P••••••• V•• L• ADV: Private Equity Fund | Buyout fund | 2022 first reported on Form ADV | $1.7B as of Aug 15, 2024 | no Form D | Unknown | |
| L••••• C•••••• P••••••• V• L• ADV: Private Equity Fund | Buyout fund | 2022 first reported on Form ADV | $1.1B as of Aug 15, 2024 | no Form D | Unknown | |
| A••••••••• B•••••• H•••••••• L•• ADV: Private Equity Fund | Feeder or parallel | 2022 first reported on Form ADV | $411M as of Nov 28, 2022 | no Form D | Wound down | |
| L••••• C••••••••• V• L• ADV: Private Equity Fund | Co-investment vehicle | 2022 first reported on Form ADV | $91.8M as of Aug 15, 2024 | no Form D | Unknown | |
| L••••• C••••••••• V•• L• ADV: Private Equity Fund | Co-investment vehicle | 2022 first reported on Form ADV | $69.5M as of Aug 15, 2024 | no Form D | Unknown | |
| L••••• E••••••••• L•• • S••••• 1• ADV: Private Equity Fund | buyout or unlabelled | 2022 first reported on Form ADV | $25.4M as of Aug 15, 2024 | no Form D | Unknown | |
| L••••• A••••••••• E••••••• F••• L•• • S••••• 2••• ADV: Private Equity Fund | Feeder or parallel | 2022 year in the fund name | $418,800 as of Aug 15, 2024 | no Form D | Early deployment | |
| L••••• M••• F••• A••••••••• L• ADV: Private Equity Fund | buyout or unlabelled | 2021 first reported on Form ADV | $212M as of Nov 28, 2022 | no Form D | Wound down | |
| L••••• A••••• A••••••••• L• ADV: Private Equity Fund | buyout or unlabelled | 2021 first reported on Form ADV | $31.7M as of Nov 28, 2022 | no Form D | Wound down | |
| L••••• S••••••••• C•••••• F••• L• ADV: Private Equity Fund | buyout or unlabelled | 2020 first reported on Form ADV | $369M as of Aug 15, 2024 | no Form D | Active deployment | |
| L••••• S••••••••• C•••••• F••••• L• ADV: Private Equity Fund | Feeder or parallel | 2020 first reported on Form ADV | $120M as of Aug 15, 2024 | no Form D | Active deployment | |
| L••••• C•••••• P••••••• I••• L• ADV: Private Equity Fund | Buyout fund | 2018 first reported on Form ADV | $1.3B as of Aug 15, 2024 | no Form D | Unknown | |
| L••••• C•••••• P••••••• I• L• ADV: Private Equity Fund | Buyout fund | 2018 first reported on Form ADV | $969M as of Aug 15, 2024 | no Form D | Unknown | |
| S• A••••••••• L• ADV: Private Equity Fund | buyout or unlabelled | 2018 first reported on Form ADV | $253M as of Nov 28, 2022 | no Form D | Wound down | |
| L••••• C•••••• P••••••• I•• L• ADV: Private Equity Fund | Buyout fund | 2015 first reported on Form ADV | $377M as of Aug 15, 2024 | no Form D | Harvest | |
| L••••• C•••••• P••••••• I•••• L• ADV: Private Equity Fund | Buyout fund | 2015 first reported on Form ADV | $326M as of Aug 15, 2024 | no Form D | Harvest | |
| L••••• C•••••• P••••••• I• L• ADV: Private Equity Fund | Buyout fund | unknown | $209M as of Aug 15, 2024 | no Form D | Unknown | |
| L••••• C•••••• P••••••• I••• L• ADV: Private Equity Fund | Buyout fund | unknown | $31.1M as of Aug 15, 2024 | no Form D | Unknown | |
| L••••• C•••••• P••••••••• L• ADV: Private Equity Fund | Buyout fund | unknown | $9,000 as of Apr 22, 2021 | no Form D | Wound down | |
| L••••• C•••••• P••••••• L• ADV: Private Equity Fund | Buyout fund | unknown | $0 as of Apr 22, 2021 | no Form D | Wound down |
Team
7 current, 2 former
Managing partner (2)
- B•••• C••••••••• M••••• · Co-Founder and Partner · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- B•••• C••••••••• M••••• · Co-Founder and Partner · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
Partner (3)
- A•••••• B•••••• D•••• · Limited Partner · since May 1, 2024 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- B•••• C••••••••• M••••• · Limited Partner · since May 1, 2024 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- P••••• S••••• · Partner · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
Platform (2)
- D••••••• W••••• V••••••••• · Chief Compliance Officer & Chief Financial Officer · since Jun 1, 2010 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- J••••••• C•••• R••••• · General Counsel · since Apr 1, 2024 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
2 former (kept with end dates)
- E••• C•••••••• L••••• · Managing Member · Jun 1, 2004 to Jul 14, 2017 Inference
- J••• E••• N••• · Special Member · Dec 1, 2005 to Mar 29, 2019 Inference
Portfolio
55 relationships, 0 platforms, 0 add-ons
Transactions
4 on record
| Date | Type | Target | This firm’s role | Source |
|---|---|---|---|---|
| Aug 24, 2026 | Exit to a strategic buyer | A•••••• | Strategic acquirer (confirmed) | prnewswire.com |
| Aug 24, 2026 | Type not stated | A•••••• | Sponsor (confirmed) | linden.com |
| Feb 12, 2026 | Growth investment | R••••••• B••••••••• | Seller (confirmed) | linden.com |
| Aug 2, 2024 | Exit to a strategic buyer | V•••• C••• | Seller (confirmed) | leonardgreen.com |
Placement agents, lenders, advisers and co-investors
6 relationships
Placement agents (2)
- P•• P••••••• L• 11 shared · very strong · last Jan 1, 2023
- P••• H••• G•••• L•• 6 shared · very strong · last Jan 1, 2020
Lenders (2)
- M••••• F•••••••• 1 shared · one time · last Aug 24, 2026
- A•••••• C•••••• 1 shared · one time · last Aug 24, 2026
Financial advisers (2)
- H••••••• L•••• 1 shared · one time · last Aug 24, 2026
- C••••• F••••••••• 1 shared · one time · last Aug 24, 2026
LP commitments
2 disclosed
- C••••••••• S•••• T•••••••• R••••••••• S••••• $100M calstrs.com
- A••••• P•••••••• F••• C••••••••• $70.0M apfc.org
Events
9 most recent
- Aug 24, 2026L••••• Announces Partnership with A••••••Platform investmentFactA••••••Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- Aug 24, 2026August 24, 2026 L••••• Announces Partnership with A••••••
- Mar 25, 2026L••••• C•••••• P•••••••: Private Equity Funds on Form ADV 19 (2024 extract) -> 28 (roster 2026-09-01)
- Feb 12, 2026February 12, 2026 R••••••• B••••••••• receives strategic investment from Cinven, adding new partner alongside L••••• Capit...
- Feb 2, 2026February 2, 2026 B••••• Appoints Dr. Auro Nair as Chief Executive Officer
- Dec 31, 2025A••••• P•••••••• F••• C••••••••• reports L••••• C•••••• P••••••• VI LP: $70,000,000 committedLp commitment disclosedFactA••••• P•••••••• F••• C•••••••••Public pension private-markets disclosures, read through the venture lane's LP report tape
- Jun 30, 2025C••••••••• S•••• T•••••••• R••••••••• S••••• reports L••••• C•••••• P••••••• VI LP: $100,000,000 committed, vintage 2025Lp commitment disclosedFactC••••••••• S•••• T•••••••• R••••••••• S•••••Public pension private-markets disclosures, read through the venture lane's LP report tape
- Aug 2, 2024V•••• C••• Receives Strategic Investment From Berkshire Partners, Leonard Green & Partners, and L••••• C•••••• P•••••••
- Feb 14, 2012L••••• C•••••• P••••••• first filed Form ADV in the extract (IA)
Across the graphs
L••••• C•••••• P••••••• is the same institution as 3 records in Independent Sponsors, RIA and Wealth and Allocators.
Independent Sponsors1RIA and Wealth1Allocators1
Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.
Checking your plan…